Lipid inCode genetic study

Description

Familial Hypercholesterolemia is a common genetic disorder, manifested by elevated levels of LDL cholesterol in the blood.

Individuals with this pathology are considered patients at high cardiovascular risk, since they usually present cardiovascular diseases at an early age (<55 years), such as myocardial infarction and stroke.

Lipid inCode analyzes the genes of interest linked to Familial Hypercholesterolemia, Autosomal Recessive Hypercholesterolemia and Lysosomal Acid Lipase Deficiency, and characterizes them at the functional level.

In the event that one or more genetic variants of interest have been identified in the first person of a family to be analyzed (called Index Case), it is always recommended to perform a family cascade diagnosis.

Familial testing for the diagnosis of familial hypercholesterolemia 200 €

Read more about the Lipid inCode genetic study